Zai Lab: Share count up as options exercised

Zai Lab Limited, a biopharmaceutical company, announced an increase in its issued ordinary shares for the month ended August 31, 2025. The total number of issued shares (excluding treasury shares) rose by 6,844,290, bringing the total to 1,117,628,030 ordinary shares. This expansion was predominantly due to the exercise of share options under various incentive plans.

The total funds raised from the exercise of options during the month amounted to $429,955.72. Under the 2015 Equity Incentive Plan, 8,082,630 shares were exercised, with 6,844,290 satisfied by newly issued shares and 1,238,340 by existing issued shares. The 2017, 2022, and 2024 Equity Incentive Plans also saw exercises of 55,850, 50,420, and 1,500 shares, respectively, all satisfied by existing issued shares.

As of the close of the month, 426,395,100 ordinary shares were held in the form of American Depositary Shares. No treasury shares were transferred out or decreased during the reporting period.